Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1

Interventions

Cyclophosphamide 5 fludarabine 4 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3 Gemcitabine 3 fludarabine phosphate 2 endostar protein 2 Melphalan 2 Etoposide 2 Doxorubicin 2 Cisplatin 2 Alemtuzumab 2 thymoglobulin 1 spartalizumab 1 selinexor 1 pembrolizumab 1 Vindesine 1 Vincristine 1 Sensitivity and Specificity 1 Rituximab 1 Prednisone 1 Prednisolone 1 Methylprednisolone 1 Interleukin-2 1 Flavin-Adenine Dinucleotide 1 Epirubicin 1 Endostatins 1 Drug Therapy 1 Dexamethasone 1 Cytarabine 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, T-Cell × Flavin-Adenine Dinucleotide × Clear all

NCT00840385 2010-09-15

FAD

Fudan University

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡